Therapy for Ataxia Telangiectasia

About Matrix Biomed

Matrix Biomed is a private, pre-revenue biotech company leveraging a proprietary gene network analysis platform to discover and develop gene-based therapeutics. Its core strategy involves mapping gene regulatory networks to identify and revert abnormal gene expression patterns in diseases, with an initial pipeline aimed at oncology supportive care and direct cancer treatment. The company appears to be in a pre-clinical or early clinical stage, with a website last updated in 2018, indicating potential dormancy or a very early-stage operational status.

Therapeutic Areas